
|Articles|January 6, 2005
Combination treatment increases survival in high-risk PCa patients
A combination of brachytherapy and external radiation plus androgen deprivation gives prostate cancer patients with high-risk disease a better chance of survival than patients treated with radiation alone, according to a study in the International Journal of Radiation Oncology*Biology*Physics (2005; 61:32-43).
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves first-line Zenflow system for the treatment of BPH
2
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
3
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
4
FDA approves gepotidacin for uncomplicated urogenital gonorrhea
5















